Molecular Partners's total assets for Q2 2025 were CHF124.25M, a decrease of -11.94% from the previous quarter. MOLN total liabilities were CHF17.59M for the fiscal quarter, a 36.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.